SOURCE: Aldagen

November 19, 2007 11:40 ET

Aldagen to Present at 19th Annual Piper Jaffray Health Care Conference

DURHAM, NC--(Marketwire - November 19, 2007) - Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen, will be presenting at the 19th Annual Piper Jaffray Health Care Conference taking place from November 27-29 in New York, NY. During the presentation, Mr. Amick will provide an overview of the company including recent clinical and strategic developments.

The following are specific details of Aldagen's presentation at the conference:

19th Annual Piper Jaffray Health Care Conference

Date: Tuesday, November 27, 2007

Time: 2:50 PM

Location: The Pierre Hotel New York

Room: Regency B

About Aldagen, Inc.

ALDAGEN is a biotechnology company advancing a pipeline of clinical-stage regenerative therapies. The Company has three product candidates in clinical development for chronic heart failure, critical limb ischemia and pediatric metabolic disorders and malignancies. ALDAGEN's therapeutics are produced by a proprietary technology platform that selects potent, adult stem and progenitor cells for therapeutic use. The platform yields a broad range of therapeutic cells that can be used rapidly, without culture or expansion. To learn more about ALDAGEN, please visit www.aldagen.com.

Contact Information